Resources

Publications

05/26/2023
- Oncology
Pathway Enrichment Analysis in Tumors With High Mutation Burdens and Interferon-G Signature Expression: A Pan Cancer Analysis
ASCO 2023
05/26/2023
- Oncology
Integrated Clinical, Pathologic, and Genetic Data in a Racially Diverse Hereditary Breast Cancer Cohort
ASCO 2023
05/26/2023
- Oncology
Molecular Characterization of Resistance to Immune Checkpoint Inhibitor and Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer
ASCO 2023
05/26/2023
- Oncology
Clinical Outcomes Among Patients With Advanced Non-Small Cell Lung Cancer Who Received Targeted Therapy in a Real-World Setting
ASCO 2023
05/26/2023
- Oncology
Association of Tumor Homologous Recombination Deficiency (HRD) Score With Immune Checkpoint Inhibitor Benefit in Metastatic Clear Cell Renal Cell Carcinoma
ASCO 2023
05/26/2023
- Oncology
Renal Cell Carcinoma With Metastasis to the Pancreas: Genomic Signatures and Clinical Outcomes
ASCO 2023
05/26/2023
- Oncology
Next Generation Sequencing (NGS) Testing for Cancer Patients at a Safety NET Hospital
ASCO 2023
05/26/2023
- Oncology
RNA Sequencing To Characterize Pathways in EGFR-Mutated Non-Small Cell Lung Cancer
ASCO 2023
05/26/2023
- Oncology
Analysis on Real-World Chemotherapy Outcomes in Patients (Pts) With Tyrosine Kinase Inhibitor (TKI) Resistant Advanced EGFR-Mutant Non–Small-Cell Lung Cancer (NSCLC) in the United States
ASCO 2023
05/26/2023
- Oncology
Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients With De Novo Advanced or Metastatic (Stage IIIB–IV) Non-Small Cell Lung Cancer in a Real-World Setting
ASCO 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35